Search clinical trials for: thrombotic risk

Total 16142 results

Centre Hospitalier Intercommunal de Toulon La Seyne...
Assistance Publique Hopitaux De Marseille; F-CRIN INNOVTE Research Network

Not yet recruiting

DVT Burden and the Risk of Post-thrombotic Syndrome (DVT-Burden)

Postthrombotic Syndrome

France
University of Leicester
University Hospitals, Leicester; British Heart Foundation

Recruiting

The Relationship Between Controlling Risk Factors and Cerebral Haemodynamics in Lacunar Stroke (LACUNAR_CA)

Lacunar Stroke

United Kingdom
University of California, San Francisco
Jazz Pharmaceuticals

Not yet recruiting

Defibrotide Prophylaxis of Transplant Associated-Thrombotic Microangiopathy for Neuroblastoma

Thrombotic Microangiopathies | Neuroblastoma | High-risk Neuroblastoma | Transplant-Associated Thrombotic Microangiopathy

United States
University Hospital, Strasbourg, France

Recruiting

Performance Evaluation of the Biological Diagnosis of HIT (HIT)

Heparin-induced Thrombocytopenia (HIT)

France
Assistance Publique Hopitaux De Marseille

Recruiting

Evaluation of the Effectiveness of Platelet-based and Microvesicle-based Assays to Predict Thrombotic and Bleeding Risk in Chronic Kidney Disease Patients With Acute Coronary Syndrome (INNOV CKD 1)

Chronic Kidney Disease stage3

France
Omeros Corporation

Recruiting

Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMA

Thrombotic Microangiopathies | Hematopoietic Stem Cell Transplantation

United States, Germany, Israel, Netherlands, Spain
Cwm Taf University Health Board (NHS)
Cardiff Metropolitan University

Recruiting

Extracellular Vesicles and Dysregulated Coagulation in the Prediction of Stroke (PREDICT-EV)

Transient Ischemic Attack | Coagulation Disorder | Stroke, Ischemic

United Kingdom
Sohag University

Not yet recruiting

" Effect of Single-nucleotide Polymorphism of CD40 Gene rs1883832 C/T on the Risk of Immune Thrombocytopenic Purpura "

Immune Thrombocytopenic Purpura

Egypt
Assistance Publique Hopitaux De Marseille

Not yet recruiting

Study of the Prognostic Value of the Coagulolytic Balance Dependent on Circulating Microvesicles in the Occurrence of Thrombotic Events After Total Knee Replacement in Orthopedic Surgery. (MOTiVE)

Knee Prosthesis

France
Peking University People's Hospital
Qilu Hospital of Shandong University; Beijing Tongren Hospital; Beijing Hospital and other collaborators

Not yet recruiting

Zanubrutinib and Eltrombopag as Second-line Treatment in Adults With Primary Immune Thrombocytopenia

Immune Thrombocytopenia

China
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Thrombin Generation Assay to Assess Thrombotic Risk in Nephrotic Patients (TGANephrotic)

Nephrotic Syndrome

France
Peking University Third Hospital

Not yet recruiting

Risk Factors and the Effect of Plasma Exchange on Prognosis of Pregnancy-related Thrombotic Microangiopathies

Pregnancy-related Thrombotic Microangiopathies
New York Medical College

Recruiting

Dose Dense Rituximab for High Risk Newly Diagnosed Acute Immune Thrombocytopenic Purpura (NYMC207)

Immune Thrombocytopenic Purpura

United States
University Hospital, Toulouse

Recruiting

French Adult Primary Immune Thrombocytopenia (FAITH)

Thrombocytopenia

France
Bayer
Janssen Scientific Affairs, LLC

Completed

Benefit-Risk Of Arterial THrombotic prEvention With Rivaroxaban for Atrial Fibrillation in France (BROTHER)

Atrial Fibrillation

France
AstraZeneca

Completed

Association of the Risk for Thrombotic Thrombocytopenia Syndrome and Exposure To COVID-19 Vaccines (ATTEST)

Covid-19

United Kingdom
Janssen Research & Development, LLC

Terminated

A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID-19) Infection (PREVENT-HD)

Coronavirus Disease 2019 (COVID-19)

United States
University Hospital, Bordeaux

Completed

Dietary Phytoestrogens as Risk Factors for Systemic Lupus Erythematosus (ISOLED)

Rheumatoid Arthritis | Lupus Erythematosus | Autoimmune Thrombocytopenia

France
University of Copenhagen
Swansea University

Active, not recruiting

Exercise Training and Thrombotic Risk in Post-menopausal Women (TIME)

Thrombosis | Menopause | Exercise Training | Vascular Dilation

Denmark
Imperial College Healthcare NHS Trust
Imperial College London; University of Oxford; Oxford University Hospitals NHS...

Withdrawn

SABRE: A Single-arm Prospective Study Measuring Safety and Tolerability of SARS-CoV-2 Neutralising Antibodies in High-risk Populations (SABRE)

Lymphoma | Leukemia | Immune Thrombocytopenia | SARS-CoV2 Infection | SARS-CoV-2 Acute Respiratory Disease | Myeloma | Thrombotic Thrombocytopenic Purpura (TTP)

United Kingdom
Nottingham University Hospitals NHS Trust

Active, not recruiting

Sonoclot to Evaluate Thrombotic Risk in Proteinuric Pregnancy

Chronic Kidney Diseases | Pregnancy Complications | Venous Thromboembolism | Proteinuria in Pregnancy

United Kingdom
Association des Médecins Vasculaires Hospitaliers
Sanofi; Ministry of Health, France; Daiichi Sankyo, Inc.; LEO Pharma; University...

Completed

Long Term Assessment of Post Thrombotic Syndrome : OPTIMEV Study ( SPOT ) (SPOT)

Cardiovascular Diseases | Venous Thromboembolism | Post Thrombotic Syndrome

France
Daiichi Sankyo, Inc.

Completed

Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease

Cardiac Disease

United States, Spain, Canada, Lebanon, Turkey, Austria, Croatia, Egypt, France, Hungary, India, Israel, Ukraine, United Kingdom
University Hospital, Caen

Completed

Risk Factors for Recurrence of Thrombosis or Thrombotic Extension, in the Event of Acute Non-cirrhotic Portal Vein Thrombosis Secondary to a Local Cause. (LOCAPORT)

Portal Vein Thrombosis | Local Cause

France
University Hospital, Toulouse

Completed

Risk Factors for Thrombosis in Immune Thrombocytopenia (RiFT-ITP)

Immune Thrombocytopenia

France
Central Hospital, Nancy, France

Completed

Long-term Venous Catheterization in Pediatric Anesthesia: Prevalence and Risk Factors of Dysfunction

Catheter Dysfunction

France
University of Texas Southwestern Medical Center
National Heart, Lung, and Blood Institute (NHLBI); Texas Scottish Rite Hospital...

Completed

Physical Activity in Children at Risk of Post-thrombotic Sequelae (PACT) (PACT)

Deep Vein Thrombosis | Post Thrombotic Syndrome

United States
Horsens Hospital
Aarhus University Hospital

Active, not recruiting

Frozen-thawed Embryo Transfers and Hormone Substitution on Thrombotic Risk Markers (TromboFET)

Frozen Embryo Transfer

Denmark
Bristol-Myers Squibb
Pfizer

Completed

Study to Evaluate a Single Dose of Apixaban in Pediatric Participants at Risk for a Thrombotic Disorder

Thromboembolism

United States, Canada, Mexico, Israel, Australia
Bayer
Janssen Research & Development, LLC; Colorado Prevention Center

Completed

Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Symptomatic Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities (VOYAGER PAD)

Peripheral Artery Disease

Poland, Belgium, France, Spain, China, Korea, Republic of, United States, Switzerland, Estonia, Portugal, Japan, Hungary, Canada, Netherlands, Finland, Austria, United Kingdom, Germany, Czechia, Thailand, Brazil, Denmark, Italy, Russian... and more
University of Vermont
Janssen Research & Development, LLC

Completed

Novel Biomarkers of Thrombotic Risk

Myocardial Infarction

United States
Cardioangiologisches Centrum Bethanien

Completed

Substudy - Evaluation of Patients With Iliac Vein Thrombosis

Iliac Vein Thrombosis

Germany
University Hospital, Bordeaux

Completed

Balance Benefit / Risk of Immunomodulatory Treatments at the Child and Adolescent for Autoimmune Cytopenia. (VIGICAIRE)

Immunotherapy | Immune Thrombocytopenic Purpura | Autoimmune Hemolytic Anemia | Evan Syndrome
East and North Hertfordshire NHS Trust

Completed

Assessment of Thrombotic Status in Patients at Risk of Cardiovascular Thrombosis

Coronary Artery Disease | Atrial Fibrillation

United Kingdom
University of Colorado, Denver
National Heart, Lung, and Blood Institute (NHLBI); Genentech, Inc.; RTI International and other collaborators

Withdrawn

Pediatric High-Risk Deep Venous Thrombosis Lytic Outcomes Trial (PHLO)

Venous Thrombosis | Deep Vein Thrombosis | Post-Thrombotic Syndrome
Shandong University
Shandong Provincial Hospital; Qianfoshan Hospital; Traditional Chinese Medicine... and other collaborators

Unknown

The Association Between Platelet Reactivity and Bleeding Risk in Adult ITP

Immune Thrombocytopenia

China
Chinese Academy of Medical Sciences, Fuwai Hospital
Zhejiang Otsuka Pharmaceutical Co., Ltd.; Haemonetics Corporation; Beijing Municipal...

Completed

Clopidogrel Response Evaluation and AnTi-Platelet InterVEntion in High Thrombotic Risk PCI Patients (CREATIVE)

Coronary Heart Disease

China
Odense University Hospital
Aarhus University Hospital; Region of Southern Denmark; Danish Heart Foundation

Completed

Systematic Screening for Risk-factors for Ulcer Bleeding Before Anti-thrombotic Treatment

Peptic Ulcer Hemorrhage | Coronary Occlusion/Thrombosis

Denmark
Vanderbilt University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

The Role of Platelet Surface α2β1 Integrin Expression as a Risk Factor in Thrombotic and/or Bleeding Complications

Genetic Polymorphism

United States
Marco Valgimigli

Unknown

Zotarolimus-eluting Endeavor Sprint Stent in Uncertain DES Candidates (ZEUS) Study (ZEUS)

Coronary Artery Disease

Italy, Switzerland, Portugal, Hungary
University of Leeds

Unknown

Cardiovascular Prophylaxis for Postmenopausal Women

Cardiovascular Disease

United Kingdom
University of North Carolina, Chapel Hill
University of Pennsylvania; Centers for Disease Control and Prevention

Not yet recruiting

Improving Outcomes and Reducing Disparities for Patients With Inflammatory Bowel Disease Through Epidemiology and Enhanced Disease Management (PROMOTE IBD)

Inflammatory Bowel Diseases | Crohn Disease | Ulcerative Colitis | Colitis

United States
University Hospital, Bordeaux

Not yet recruiting

COmbined pLaTelet and eRythrocyte AutotransfusioN During Cardiac surgEry (COLTRANE) Trial (COLTRANE)

On-pump Cardiac Surgery | High Risk for Bleeding | Autotransfusion

France
University Hospital, Grenoble

Recruiting

Effects of a Lifestyle and Sleep Intervention in Non-exercising Adults (SPIRAL+)

Lifestyle Risk Reduction | Inactivity, Physical

France
European Association of Urology Research Foundation
National Cancer Institute (NCI); UMC Utrecht; Erasmus Medical Center; University... and other collaborators

Not yet recruiting

Prostate Cancer Awareness and Initiative for Screening in the European Union (PRAISE-U)

Prostate Cancer
China National Center for Cardiovascular Diseases

Not yet recruiting

Effect of Xuesaitong Soft Capsules on Major Risk Factors in Patients With Coronary Heart Disease

Coronary Heart Disease

China
Hospices Civils de Lyon

Recruiting

Campylobacter Spp. Bone and Joint Infection: a Retrospective Cohort Study (Campylo-BJI)

Campylobacter Infections

France
University of Oviedo

Not yet recruiting

Predictors of Muscle Injury Risk in Non-professional Football Players

Sport Injury

Spain
Tanta University

Recruiting

Trendelenburg Maneuver Versus Passive Leg Raising Test for Fluid Responsiveness in High-Risk Surgical Patients

Passive Leg Raising | High-Risk Surgical Patients | Trendelenburg Maneuver

Egypt
Xuanwu Hospital, Beijing
Chongqing Institute of Green and Intelligent Technology, Chinese Academy...

Not yet recruiting

Risk Warning Model of Postoperative Delirium and Long-term Cognitive Dysfunction in Elderly Patients

Postoperative Delirium | Surgery | Postoperative Neurocognitive Disorder

Search clinical trials for: thrombotic risk

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jordan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations